In the WHO European Region, it is estimated that at least 17 million individuals may have experienced Long COVID in 2020 and 2021. Long COVID is characterised by the persistence of COVID-19 symptoms beyond 3 months and is causing both personal suffering and significant burden on health systems and the economy.
On the 2nd of March 2023, COVIRNA organised a webinar aiming to shed light on patient-centred approaches for addressing Long COVID in the EU. A range of cardiopulmonary symptoms and cardiovascular abnormalities have been identified in Long COVID patients. However, these vary from patients to patients and are not always predictable, which highlights the need for early diagnosis and person-centred approaches and care models. To help identify COVID-19 patients at risk of developing cardiovascular complications, the EU Horizon Europe work programme 2021-2022 has provided funding to COVIRNA project to develop a diagnostic test to improve individualised surveillance, care and follow-up of COVID-19 patients.
You can now watch the recording of the webinar on ‘Patient-centred approaches to Long Covid’ here
